Skip to content

Additional Hyperbaric Oxygen After Lower Extremity Amputation

Additional Hyperbaric Oxygen After Lower Extremity Amputation - A Randomized Controlled Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03594344
Acronym
AHOLEA
Enrollment
120
Registered
2018-07-20
Start date
2018-07-04
Completion date
2026-12-31
Last updated
2025-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amputation, Claudication, Intermittent, Critical Limb Ischemia, Diabetes Mellitus, Diabetic Angiopathy, Diabetic Foot, Diabetic Neuropathies, Lower Extremity Ulcer, Osteomyelitis

Keywords

Diabetic foot, Diabetes, Lower extremity amputation, Hyperbaric oxygen therapy, HBOT

Brief summary

This study evaluates the effect of additional hyperbaric oxygen therapy after lower extremity amputation. The patients will be randomized after amputation to either a treatment group receiving hyperbaric oxygen therapy, or control group.

Detailed description

Hyperbaric oxygen therapy has been used to treat hard to heal wounds for decades. Amputation, especially distal lower extremity amputations have the same problem with healing and patients often need to be re-amputated more proximally. In these patients oxygen levels are often the decisive factor. Providing additional oxygen under hyperbaric conditions will increase tissue oxygen concentration sufficient for the amputation stump to heal. This will give the patients a more distal amputation with better condition for ambulation.

Interventions

PROCEDUREHyperbaric oxygen therapy

Breathing 100% oxygen for 30+30+30 min at 2,4 ATA. in a multiplace hyperbaric chamber. Total of 30 sessions

Sponsors

Diakonhjemmet Hospital
CollaboratorOTHER
Oslo University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Lower extremity amputation because of chronic wound, osteomyelitis, ischemia, necrosis. * Fit to receive hyperbaric oxygen therapy determined by an anesthesiologist/Hyperbaric Medicine Physician. * Able to cooperate and follow up appointments * Included within 7 days after final surgery

Exclusion criteria

* Not fulfilling inclusion criteria * Pregnancy * Dementia

Design outcomes

Primary

MeasureTime frameDescription
Intact skin with no abnormal openings at the site of primary amputation12 weeksHealed and intact skin at the site of primary amputation without need for more proximal amputation.Healed amputation is defined as epithelialization of the wound examined by a orthopedic surgeon. Level of primary amputation is decided by the surgeon. Planned 2-session amputation, for example Guillotine amputation with a final amputation later is considered being primary amputation. Healed primary amputation will be measured at 12 weeks.

Secondary

MeasureTime frameDescription
Intact skin with no abnormal openings at the site of amputation at 9 months9 monthsHealed and intact skin at the site of amputation at follow up 9 months. Will be assessed if the wound has not healed at 6 months. Healed amputation is defined as epithelialization of the wound examined by a orthopedic surgeon.
Intact skin with no abnormal openings at the site of amputation at 1 year12 monthsHealed and intact skin at the site of amputation at follow up at 1 year. Healed amputation is defined as epithelialization of the wound examined by a orthopedic surgeon.
Time to closed and intact skin at the site of amputation1 yearTime to closed and intact skin at the site of amputation is the defined as how many weeks until complete healing of amputation. Healed amputation is defined as epithelialization of the wound examined by a orthopedic surgeon and no abnormal openings.
Reamputations1 yearThe total number of reamputations done within the follow-up period of 1 year.
Number of wound revision1 yearThe total numbers of surgical wound revision done in operating theater.
Intact skin with no abnormal openings at the site of amputation at 6 months6 monthsHealed and intact skin at the site of amputation at follow up 6 months. Healed amputation is defined as epithelialization of the wound examined by a orthopedic surgeon.
Visual analog pain scale (VAS)baselineVisual analog pain scale (VAS) is a measurement of pain intensity between 0 and 10. 0 = no pain, 10 = worst imaginable pain.
RAND 36-Item Short Form Health SurveybaselineRAND 36-Item Short Form Health Survey (SF-36) measures 8 health domains with the total of 36 questions. The domains are physical functioning, bodily pain, role limitations due to physical health problems, role limitations due to personal or emotional problems, emotional well-being, social functioning, energy/fatigue, and general health perceptions. There is also 1 question that measures change in self-perceived health.The question answers is translated to a number between 0 meaning worst selv-perceived health and 100 meaning the best possible quality of health.Each domain will be presented with a number between 0 and 100.
Quality of Life in Neurological Disorders - Lower extremity function - Mobility Short formbaselineQuality of Life in Neurological Disorders (Neuro-QoL) - Lower extremity function - Mobility Short form measures lower extremity function with 8 items scoring from 1 unable to do, to 5 which is doing it without any difficulty. Scores will be presented as total points from 5-40.
The Foot and Ankle Ability Measure (FAAM)baselineThe Foot and Ankle Ability Measure (FAAM) is a self-report outcome instrument developed to assess physical function for individuals with foot and ankle related impairments. FAAM contains 21 items that measure different functions. Each answer get a score from 0 to 4. The score total will be reported were 0 is the lowest and 84 is the highest possible score.
Days in hospital during follow up1 yearTotal number of days in hospital during 1 year follow up

Countries

Norway

Contacts

Primary ContactJonas Rydinge, MD
jonryd@ous-hf.no+4792291795
Backup ContactElisabeth I Ellingsen Husebye, MD, PhD
uxngng@ous-hf.no+47 95133773

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026